Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.05.2024 | Case report

Ipilimumab/Nivolumab

Hyperthyroidism and hypophysitis

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Loughner CL, et al. A Tale Of Two Endocrinopathies: Hyperthyroidism And Hypophysitis In A Case of Metastatic Melanoma. Journal of the Endocrine Society 6 (Suppl. 1): A154 abstr. LBSAT308, Dec 2022. Available from: URL: https://dx.doi.org/10.1210/jendso/bvac150.314 [abstract] Loughner CL, et al. A Tale Of Two Endocrinopathies: Hyperthyroidism And Hypophysitis In A Case of Metastatic Melanoma. Journal of the Endocrine Society 6 (Suppl. 1): A154 abstr. LBSAT308, Dec 2022. Available from: URL: https://​dx.​doi.​org/​10.​1210/​jendso/​bvac150.​314 [abstract]
Metadaten
Titel
Ipilimumab/Nivolumab
Hyperthyroidism and hypophysitis
Publikationsdatum
01.05.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58237-8

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Phenytoin